Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a small update to the page's version tag.
    Difference
    0.1%
    Check dated 2026-08-29T18:49:31.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision tag changed from v3.6.4 to v3.6.5. This indicates a minor update or patch to the page's template/metadata rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T16:13:44.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update appears to reflect backend or formatting adjustments rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-25T10:31:52.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, reflecting a small administrative update to the page. It does not indicate changes to the study details or outcomes.
    Difference
    0.1%
    Check dated 2026-07-03T22:41:46.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, indicating a software version bump; this likely reflects minor fixes or enhancements without altering the study details displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:12:06.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    New sections for user guidance (How to Read a Study Record, Common Questions, How to Join a Study) and a No longer looking for participants notice were added, while the Intervention/Treatment header was standardized. The sponsor designation was updated to Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest and the page revision shows v3.6.0 (replacing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-12T16:39:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.